DONISI, CLELIA
 Distribuzione geografica
Continente #
EU - Europa 17.436
NA - Nord America 530
AS - Asia 233
AF - Africa 5
OC - Oceania 2
Totale 18.206
Nazione #
IT - Italia 17.240
US - Stati Uniti d'America 520
CN - Cina 124
SE - Svezia 90
SG - Singapore 47
IN - India 21
FI - Finlandia 19
DE - Germania 18
NL - Olanda 17
GB - Regno Unito 16
KR - Corea 15
FR - Francia 10
CA - Canada 9
BE - Belgio 6
HK - Hong Kong 6
IE - Irlanda 5
TH - Thailandia 4
VN - Vietnam 4
AT - Austria 3
CZ - Repubblica Ceca 3
ES - Italia 3
GR - Grecia 3
IR - Iran 3
JP - Giappone 3
AU - Australia 2
SC - Seychelles 2
BJ - Benin 1
CH - Svizzera 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 18.206
Città #
Cagliari 16.156
Uta 981
Boardman 94
Nyköping 74
Chandler 66
Ashburn 47
Fairfield 42
Shanghai 32
Santa Clara 29
New York 28
Singapore 28
Rome 26
Seattle 18
Helsinki 17
Houston 17
Seoul 15
Pune 14
Wilmington 14
San Diego 13
Woodbridge 13
Boston 12
Cambridge 12
Amsterdam 11
Guangzhou 10
Munich 10
Los Angeles 9
Shenzhen 9
Beijing 8
Toronto 8
London 6
Paris 6
Menlo Park 5
Sassari 5
Dong Ket 4
Hefei 4
La Maddalena 4
Milan 4
Naples 4
Zhengzhou 4
Chicago 3
Dublin 3
Hong Kong 3
Islington 3
Naaldwijk 3
Peristeri 3
San Francisco 3
Turin 3
Vienna 3
Wuhan 3
Brussels 2
Delhi 2
Don Mueang 2
Enna 2
Godo 2
Hangzhou 2
Jacksonville 2
Jinhua 2
Kyjov 2
Leuven 2
Livorno 2
Molenbeek-Saint-Jean 2
Nakano 2
Nanjing 2
Pamplona 2
Pisa 2
Romainville 2
Salerno 2
Sydney 2
Washington 2
Xian 2
Yantai 2
Alexandria 1
Almaty 1
Amgaon 1
Ankara 1
Basel 1
Bergamo 1
Bilbao 1
Brno 1
Cairo 1
Chandigarh 1
Chennai 1
Clifton 1
Cotonou 1
Council Bluffs 1
Ebisu 1
Exeter 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Heidelberg 1
Hounslow 1
Jiaxing 1
Jinan 1
Lappeenranta 1
Lecce 1
Magelang 1
Manila 1
Mercato San Severino 1
Miami Beach 1
Totale 17.962
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.610
New therapeutic targets in pancreatic cancer 1.504
Immunotherapy and Cancer: The Multi-Omics Perspective 1.452
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.223
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.085
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 847
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 844
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 802
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 772
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 657
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 614
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 601
Uncovering key targets of success for immunotherapy in pancreatic cancer 575
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 564
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 546
BRCA-mutant pancreatic ductal adenocarcinoma 476
Immune Checkpoint Inhibitors in the Treatment of HCC 471
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 421
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 413
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 383
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 379
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 353
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 296
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 149
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 82
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 80
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 64
Early taxane exposure and neurotoxicity in breast cancer patients 33
Totale 18.296
Categoria #
all - tutte 26.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 31 8 6 7 4 11
2020/20211.659 15 25 17 585 324 205 58 116 47 116 76 75
2021/20221.168 69 63 4 29 60 100 61 89 77 116 228 272
2022/20233.703 325 526 339 242 270 296 202 311 297 407 314 174
2023/20243.429 159 117 113 184 273 553 549 245 243 239 368 386
2024/20258.270 2.859 3.319 854 923 315 0 0 0 0 0 0 0
Totale 18.296